Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126633891 | 12663389 | 1 | I | 20160728 | 20160804 | 20160818 | 20160818 | EXP | US-ACORDA-ACO_127040_2016 | ACORDA | 0.00 | F | Y | 47.62000 | KG | 20160818 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126633891 | 12663389 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | Y | U | 22250 | 10 | MG | TABLET | BID | ||||
| 126633891 | 12663389 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10MG, BID | Y | U | 22250 | TABLET | |||||||
| 126633891 | 12663389 | 3 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG , BID | Y | U | 22250 | TABLET | |||||||
| 126633891 | 12663389 | 4 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | UNK | U | 0 | ||||||||||
| 126633891 | 12663389 | 5 | C | Rituximab | RITUXIMAB | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126633891 | 12663389 | 1 | Gait disturbance |
| 126633891 | 12663389 | 2 | Multiple sclerosis |
| 126633891 | 12663389 | 4 | Product used for unknown indication |
| 126633891 | 12663389 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126633891 | 12663389 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126633891 | 12663389 | Abasia | |
| 126633891 | 12663389 | Condition aggravated | |
| 126633891 | 12663389 | Confusional state | |
| 126633891 | 12663389 | Disturbance in attention | |
| 126633891 | 12663389 | Gait disturbance | |
| 126633891 | 12663389 | Insomnia | |
| 126633891 | 12663389 | Trigeminal neuralgia | |
| 126633891 | 12663389 | Wheelchair user |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126633891 | 12663389 | 1 | 2010 | 0 | ||
| 126633891 | 12663389 | 3 | 20160729 | 20160801 | 0 | |
| 126633891 | 12663389 | 4 | 201106 | 201112 | 0 | |
| 126633891 | 12663389 | 5 | 2014 | 0 |